Loading quotes...
Forecast
The analysts' average price target is €616.71 (+0.44%). The median is €654.23 (+6.55%).
| Buy |
36 |
| Hold |
7 |
| Sell |
0 |
News Go to news feed
Thermo Fisher benefits from AI-driven demand in labs
AI increases the number of drug candidates and scientific hypotheses, leading to greater demand for physical lab testing. This is likely to trigger a new investment cycle for lab equipment and services, from which Thermo Fisher can directly benefit. Rising demand for analytical and testing capacity is driving the company’s growth story in the AI era. » More on finanzen.net
Thermo Fisher Scientific announces strategic realignment and focuses on margin growth
Thermo Fisher Scientific benefits from structural trends in biopharmaceutical research and is pursuing a strategic realignment to strengthen its diversified business model. The company supplies laboratory equipment, analytical instruments, reagents and diagnostic solutions and views demographic drivers as growth catalysts. Results for the third quarter, to be released on October 21, are regarded as an important indicator of margin development. » More on finanzen.net
Thermo Fisher builds infrastructure for autonomous AI laboratories as demand for lab automation rises
Around 950 AI agents analyzed over 200,000 reverse transcriptases within 21 hours and identified thousands of new candidate systems, including a previously uncharacterized enzyme system with CRISPR-like repeats. The results required experimental confirmation in the wet lab, increasing the need for automated laboratory workflows. Thermo Fisher and NVIDIA are therefore jointly expanding the infrastructure so AI agents can plan experiments, control instruments, and evaluate results in increasingly autonomous labs. » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 10.66B | 12.11% |
| Gross profit | 4.56B | 16.39% |
| Net profit | 1.51B | 9.41% |
| EBITDA | 2.2B | 9.19% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €223.28B |
Number of shares | 369.75M |
52-week high/low | €632.53 - €390.09 |
Dividend yield | 0.26% |
Dividends TTM | €1.60 |
Beta | 0.88 |
P/E ratio | 35.48 |
PEG ratio | 3.73 |
P/B ratio | 4.55 |
P/S ratio | 5.26 |
Company profile
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
| Name | Thermo Fisher Scientific Inc. |
| CEO | Marc N. Casper |
| Headquarters | Waltham,
ma USA |
| Website | |
| Sector | Health Care |
| Industry | Health Care Technology |
| IPO | 03/17/1980 |
| Employees | 125,000 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | TMO |
London Stock Exchange | 0R0H.L |
XETRA | TN8.DE |
Frankfurt | TN8.F |
Düsseldorf | TN8.DU |
Milan | 1TMO.MI |
London | 0R0H.L |
SIX | TFS.SW |
München | TN8.MU |
Wien | TMOF.VI |